Skip to content
Products
Solutions
Pricing
Resources
Company
Sign in
Request a demo
Search results
490 entries found
Venture Capital
Private Equity
Filters
Data & Research
April 2023
Healthtech shows signs of resilience amid venture downturn
Healthtech deal count declined in Q4, but deal value showed a slight uptick.
View
Data & Research
April 2023
First Cut – State of Private Markets: Q1 2023
In Q1 2023, fundraising continued to decline at most stages while valuations rebounded at Series A and B. Learn more in our preview report.
View
Data & Research
March 2023
How VCs are navigating the SaaS slump
SaaS deal counts and dollars raised are down. Here's how SaaS investors see the landscape.
View
article
March 2023
Syndicates
A syndicate is a group investors who invest in startups or companies on a deal-by-deal basis. Learn how angel-run syndicates work in the venture ecosystem.
View
Founder Education
March 2023
Angel investors
Former startup founder Marcel Van Oost breaks down tips and best practices for becoming an angel investor.
View
Data & Research
March 2023
As VC valuation step-up multiples shrink, startups feel the squeeze
Median valuations trended down for startups at every stage in Q4 2022. Here’s what founders need to know about step-up multiples before raising a new round.
View
Data & Research
March 2023
Fintech funding has fallen off a cliff—here’s what might come next
Fintech funding fell for five straight quarters following a peak in 2021. Early-stage VCs and Carta data explain what happened and what might come next.
View
Investors
March 2023
Pari-passu
Pari-passu is a type of investor preference where all preferred shareholders in a company have equal distribution rights during a liquidation event.
View
Investors
March 2023
Bull market vs. bear market
Understand key differences between a bear market and a bull market and how market fluctuations affect private fund performance.
View
Investors
March 2023
Seed valuations varied significantly by sector in 2022
Carta data shows median valuations for seed-stage startups were steady in 2022. For SaaS, hardware, healthcare, and fintech, valuations varied.
View
Carta
March 2023
Early-stage deal counts plunged in Q4, while Series B and Series C bounced back
Following a brief period of resilience, early-stage deals retreated in Q4.
View
Data & Research
February 2023
State of startup compensation, H2 2022
Startups in 2023 are facing compensation markets unlike any in recent memory.
View
Previous
35
36
37
38
39
Next